
Bonitas defends administrator switch after record financial results
Executives acknowledged the disruption caused by the June administrator switch while insisting the scheme’s long-term strategy remains on track.

Executives acknowledged the disruption caused by the June administrator switch while insisting the scheme’s long-term strategy remains on track.

The medical scheme says legacy issues contributed to post-transition challenges as members report delays with hospital authorisations and medication approvals.

The demand for GLP-1 medications as a weight-loss solution raises critical questions about accessibility, affordability, and the long-term sustainability of their use for managing obesity and diabetes.

Motsoaledi insists that equalising healthcare shouldn’t be held back by funding concerns, and he challenges the assumptions behind the cost estimates.

Aaron Motsoaledi wants to engage with with stakeholders who are in favour of universal health coverage but have objections to the NHI Act.